2012•Medical Journal of Chinese People's HealthRequires access

The clinical research of Aripiprazole combined with Clozapine in refractory schizophrenia

Shen Ping

Open publisher page 0 citations

Abstract

Objective:To study the aripiprazole combined with clozapine for the for the treatment in refractory schizophrenia therapeutic efficacy and side effect respectively.Methods:45 patients of clozapine in refractory schizophrenia combined with aripiprazole,PANSS and TESS were used to assess the therapeutic efficacy and side effect respectively before treatment、after treatment with 2、 4、 8、12 weekend.Results: The patients combined with aripiprazole PANSS scores decreased significantly(P0.05),the total side effect respectively decreased significantly(P0.05).Conclusions: Aripiprazole combined with clozapine in the treatment of refractory schizophrenia has good therapeutic efficacy,high safety,can be used as a good choice.

About this research paper

What this paper is about

Objective:To study the aripiprazole combined with clozapine for the for the treatment in refractory schizophrenia therapeutic efficacy and side effect respectively.Methods:45 patients of clozapine in refractory schizophrenia combined with aripiprazole,PANSS and TESS were used to assess the therapeutic efficacy and side effect respectively before treatment、after treatment with 2、 4、 8、12 weekend.Results: The patients combined with aripiprazole PANSS scores decreased significantly(P0.05),the total side effect respectively decreased significantly(P0.05).Conclusions: Aripiprazole combined with clozapine in the treatment of refractory schizophrenia has good therapeutic efficacy,high safety,can be used as a good choice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the aripiprazole combined with clozapine for the for the treatment in refractory schizophrenia therapeutic efficacy and side effect respectively.Methods:45 patients of clozapine in refractory schizophrenia combined with aripiprazole,PANSS and TESS were used to assess the therapeutic efficacy and side effect respectively before treatment、after treatment with 2、 4、 8、12 weekend.Results: The patients combined with aripiprazole PANSS scores decreased significantly(P0.05),the total side effect respectively decreased significantly(P0.05).Conclusions: Aripiprazole combined with clozapine in the treatment of refractory schizophrenia has good therapeutic efficacy,high safety,can be used as a good choice.

Key concepts: Aripiprazole, Clozapine, Schizophrenia (object-oriented programming), Refractory (planetary science), Medicine, Therapeutic effect, Side effect (computer science), Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinical research of Aripiprazole combined with Clozapine in refractory schizophrenia — Research Paper | ScholarLens